首页> 外文OA文献 >EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to “αS1-casein tryptic hydrolysate” and alleviation of psychological stress (ID 656, 1819, 4253) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
【2h】

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to “αS1-casein tryptic hydrolysate” and alleviation of psychological stress (ID 656, 1819, 4253) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

机译:EFsa饮食产品,营养和过敏专家组(NDa);根据第(EC)1924/2006号条例(EC)第13(1)条,证实与“αs1-酪蛋白胰蛋白酶水解物”有关的健康声称和减轻心理压力(ID 656,1819,4253)的科学意见

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to “αS1-casein tryptic hydrolysate” and alleviation of psychological stress. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituents that are the subject of the health claims are “lactium milk protein hydrolysate”, “lactium-peptide compound” and “hydrolysat de protéines de lait: milk protein hydrolysate concentrated with 1,7 % of alphaS1 decapeptide (=lactium)”. In the context of the references provided, the Panel notes that the food constituent which is the subject of the health claims is a specific commercial preparation of αS1-casein tryptic hydrolysate. The Panel considers that the specific αS1-casein tryptic hydrolysate is sufficiently characterised. The claimed effects are “helps to calm mind”, “mental state and performance”, and “stress”. The target population is assumed to be the general population. In the context of the proposed wordings and from the references provided, the Panel assumes that the claimed effects refer to alleviation of psychological stress. The Panel considers that alleviation of psychological stress might be a beneficial physiological effect. No references were provided from which conclusions could be drawn for the scientific substantiation of the claim. On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of “αS1-casein tryptic hydrolysate” and alleviation of psychological stress.
机译:根据欧洲委员会的要求,要求营养产品,营养和过敏问题小组根据(EC)1924/2006号法规第13条,就健康声明清单提供科学意见。该意见涉及与“αS1-酪蛋白胰蛋白酶水解产物”有关的健康主张的科学依据,并减轻了心理压力。科学依据是成员国在第13条健康声明综合清单中提供的信息,以及EFSA从成员国或直接从利益相关者那里获得的参考。属于健康要求主题的食品成分是“乳牛奶蛋白水解物”,“乳肽化合物”和“蛋白水解物:浓缩了1.7%αS1十肽(=乳酸)的乳蛋白水解物” 。在所提供的参考文献中,小组注意到,作为健康要求主题的食品成分是αS1-酪蛋白胰蛋白酶水解产物的特定商业制剂。专家小组认为,特定的αS1-酪蛋白胰蛋白酶解产物具有足够的特征。所声称的效果是“有助于使头脑平静”,“精神状态和表现”以及“压力”。假定目标人群为普通人群。在提议的措词和所提供的参考文献的范围内,小组认为所要求的效果是减轻心理压力。小组认为减轻心理压力可能是有益的生理作用。没有提供可以从中得出结论的科学依据的参考文献。根据提供的数据,小组得出结论,在食用“αS1-酪蛋白胰蛋白酶水解产物”与缓解心理压力之间尚未建立因果关系。

著录项

  • 作者

    Tetens Inge;

  • 作者单位
  • 年度 2011
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号